Financials·Life & Health Insurance·$5.1B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.35 | N/A | +25.53% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $-0.35 | N/A | +25.53% |
| Revenue | N/A | N/A | N/A |
Tone: Defensive
Management expressed caution regarding future performance without providing specific guidance. They highlighted challenges that may impact growth.
Management did not provide specific guidance for the upcoming quarters.
The company acknowledged ongoing challenges in the current market environment.
Oscar Health's earnings report shows a larger-than-expected loss per share, which may raise concerns among investors about the company's profitability. The stock reacted negatively, dropping 1.21%. The lack of revenue figures and guidance adds uncertainty to the outlook, leaving investors cautious about the company's future performance.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
BIONTECH SE ADR
Aug 9, 2021